Autoimmune hepatitis with eosinophilic infiltration responsive to anti-interleukin-5 receptor treatment: a case report and literature review

Published: 31 October 2023
Abstract Views: 384
PDF: 237
HTML: 33
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Inflammatory tissue damage plays a role in the onset, progression, and exacerbation of various chronic autoimmune and metabolic diseases such as autoimmune hepatitis. Here we present a case of autoimmune hepatitis with liver eosinophilic infiltrate in a severe eosinophilic asthma patient who failed conventional immunosuppressive treatment and showed improvement in gastrointestinal symptoms after anti-interleukin-5 receptor treatment. Our case highlights the potential role of eosinophils in initiating or worsening liver inflammation in autoimmune liver disease. The link between eosinophilic inflammation, barrier damage, and chronic autoimmune diseases should be considered in clinical practice.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Mu Q, Kirby J, Reilly CM, Luo XM. Leaky Gut As a Danger Signal for Autoimmune Diseases. Front Immunol 2017;23:598. DOI: https://doi.org/10.3389/fimmu.2017.00598
Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases. Hepatology 2020;72:671-722. DOI: https://doi.org/10.1002/hep.31065
Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 2019;68:1516-26. DOI: https://doi.org/10.1136/gutjnl-2019-318427
Menzies-Gow A, Corren J, Bel EH, et al. Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial. ERJ Open Res. 2019;25:00009-2019. DOI: https://doi.org/10.1183/23120541.00009-2019
Diny NL, Rose NR, Čiháková D. Eosinophils in Autoimmune Diseases. Front Immunol 2017;8:484. DOI: https://doi.org/10.3389/fimmu.2017.00484
Caruso C, Colantuono S, Ciasca G, et al. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity. Allergy 2022. Epub ahead of print. DOI: https://doi.org/10.1111/all.15466
Lohani S, Nazir S, Tachamo N, Pagolu P. Autoimmune hepatitis and eosinophilic granulomatosis with polyangiitis: a rare association, BMJ Case Rep 2017. DOI: https://doi.org/10.1136/bcr-2016-218385
Nardelli MJ, Cançado GGL, Naves GNT, et al. Autoimmune hepatitis presenting with peripheral eosinophilia: Case report and literature review. Transpl Immunol 2022;74:101671. Epub 2022 Jul 13. DOI: https://doi.org/10.1016/j.trim.2022.101671
Van Overbeke L, Van Dijck H. Idiopathic acute eosinophilic hepatitis: does it exists? Acta Gastroenterol Belg 2015;78:65-8.
Garrido I, Lopes S, Fonseca E, et al. Autoimmune hepatitis and eosinophilia: A rare case report. World J Hepatol 2023;15:311-7. DOI: https://doi.org/10.4254/wjh.v15.i2.311

Supporting Agencies

Not applicable

How to Cite

Ponziani, F. R., Caruso, C., Baglivo, I., Macagno, F., Gasbarrini, A., Santopaolo, F., Giustiniani, M. C., Colantuono, S., & Pompili, M. (2023). Autoimmune hepatitis with eosinophilic infiltration responsive to anti-interleukin-5 receptor treatment: a case report and literature review. Italian Journal of Medicine, 17(3). https://doi.org/10.4081/itjm.2023.1619